Exact Mass: 740.3191320000001
Exact Mass Matches: 740.3191320000001
Found 58 metabolites which its exact mass value is equals to given mass value 740.3191320000001
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Odevixibat
C37H48N4O8S2 (740.2913408000001)
C78276 - Agent Affecting Digestive System or Metabolism > C177170 - Ileal Bile Acid Transport Inhibitor A - Alimentary tract and metabolism > A05 - Bile and liver therapy > A05A - Bile therapy
(5S)-5-hydroxy-1,7-bis-(4-hydroxyphenyl)-3-heptanone-5-O-[2,6-bis-O-(beta-D-apiofuranosyl)-beta-D-glucopyranoside]
(3beta,5beta,16beta)-3-[(6-deoxy-4-O-beta-D-glucopyranosyl-3-O-methyl-beta-D-galactopyranosyl)oxy]-14,16-dihydroxycard-20(22)-enolide 16-formate|16beta-Formyloxy-3beta-(O4(?)beta-D-glucopyranosyl-O3-methyl-beta-D-fucopyranosyloxy)-14-hydroxy-5beta,14beta-card-20(22)-enolid|16beta-formyloxy-3beta-(O4(?)beta-D-glucopyranosyl-O3-methyl-beta-D-fucopyranosyloxy)-14-hydroxy-5beta,14beta-card-20(22)-enolide
2alpha,7beta,9alpha,10beta-13alpha-pentaacetoxy-5alpha-cinnamoyloxy-4beta,20-epoxy-taxa-11-en-1beta-ol
8-methoxyhypophyllanthin-2a-O-beta-apiofuranosyl-(1->6)-O-beta-glucopyranoside
(+)-jasplakinolide Z2
C37H49BrN4O7 (740.2784423999999)
A depsipeptide isolated from Jaspis splendens.
7-O-acetyl-5-O-benzoyl-13,15-dihydroxy-3,18-O-dinicotinoyl-14-oxo-lathyrane
C41H44N2O11 (740.2944954000001)
1beta,3beta-dihydroxypregna-5,16-dien-20-one 1-O-[O-alpha-L-rhamnopyranosyl-(1->2)-O-[beta-D-xylopyranosyl)-(1]3)]-alpha-L-arabinopyranoside]
3-O-(4-O-beta-D-glucopyranosyl-beta-D-glucopyranosyl)-3beta,14beta,16beta-trihydroxy-19-oxo-5alpha-bufa-20,22-dienolide
[1,1:4,1:4,1-Quaterphenyl]-4,4-diamine, N4,N4-di-1-naphthalenyl-N4,N4-diphenyl
N,N-Di-1-naphthalenyl-N,N-diphenyl-[quaterphenyl]-4,4-diamine
(3beta,5beta,16beta)-3-((6-Deoxy-4-O-beta-D-glucopyranosyl-3-O-methyl-beta-D-galactopyranosyl)oxy)-14,16-dihydroxycard-20(22)-enolide 16-formate
Odevixibat
C37H48N4O8S2 (740.2913408000001)
C78276 - Agent Affecting Digestive System or Metabolism > C177170 - Ileal Bile Acid Transport Inhibitor A - Alimentary tract and metabolism > A05 - Bile and liver therapy > A05A - Bile therapy
(-)-(S)-9-Fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-7H-pyrido(1,2,3-de)-1,4-benzoxazine-6-carboxylic acid, hemihydrate
C36H42F2N6O9 (740.2981186000001)
D004791 - Enzyme Inhibitors > D065607 - Cytochrome P-450 Enzyme Inhibitors > D065609 - Cytochrome P-450 CYP1A2 Inhibitors D000970 - Antineoplastic Agents > D059003 - Topoisomerase Inhibitors > D059005 - Topoisomerase II Inhibitors D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D024841 - Fluoroquinolones COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials C254 - Anti-Infective Agent > C258 - Antibiotic > C795 - Quinolone Antibiotic Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS
dimethyl-[(1S,10S,12S,13R,21S,23S)-4,8,12-trihydroxy-10-[(2R,3R,4R,5S,6S)-4-hydroxy-3,5-dimethoxy-4,6-dimethyloxan-2-yl]oxy-13-methoxycarbonyl-1,12-dimethyl-6,17-dioxo-25-oxahexacyclo[19.3.1.02,19.05,18.07,16.09,14]pentacosa-2,4,7(16),8,14,18-hexaen-23-yl]azanium
C39H50NO13+ (740.3281989999999)
[1-[(3E,6E,9E)-dodeca-3,6,9-trienoyl]oxy-3-[hydroxy-[(5R)-2,3,4,5,6-pentahydroxycyclohexyl]oxyphosphoryl]oxypropan-2-yl] (7E,9E,11E,13E)-hexadeca-7,9,11,13-tetraenoate
C37H57O13P (740.3536601999999)
[1-[(6E,9E)-dodeca-6,9-dienoyl]oxy-3-[hydroxy-[(5R)-2,3,4,5,6-pentahydroxycyclohexyl]oxyphosphoryl]oxypropan-2-yl] (5E,7E,9E,11E,13E)-hexadeca-5,7,9,11,13-pentaenoate
C37H57O13P (740.3536601999999)